Activella combined with Cycrin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Neoplasm Malignant Other Serious Female 1/11/2006 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious Female 1/13/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2004 56 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2003 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Smear Cervix Abnormal Other Serious 5/9/2002 54 Female 153 lb 4/5/2006 Lawyer United States
Primary
Secondary
Concomitant
Neoplasm Malignant Other Serious 6/11/2004 62 Female 6/16/2006 Consumer United States
Primary
Secondary
Neoplasm Malignant Other Serious 6/11/2004 62 Female 6/21/2006 United States
Primary
Secondary
Uterine Leiomyoma Hospitalization 5/9/2002 54 Female 153 lb 6/29/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/7/2006 United States
Primary
Secondary
Concomitant
Metastases To Lymph Nodes Other Serious 11/7/2002 56 Female 8/15/2006 United States
Primary
Secondary
Papillary Serous Endometrial Carcinoma Other Serious 6/11/2006 62 Female 9/11/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Papillary Serous Endometrial Carcinoma Other Serious 6/11/2006 Female 175 lb 2/2/2007 United States
Primary
Secondary
Pharmaceutical Product Complaint Other Serious 5/9/2002 Female 153 lb 2/8/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/1/2001 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/14/2002 59 Female 165 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/2002 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2004 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/17/2004 56 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Metastatic Required Intervention 9/27/2002 75 Female 144 lb 7/5/2007 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/5/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/30/2002 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/18/2007 United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 6/11/2004 Female 2/1/2008 Lawyer United States
Primary
Secondary
Uterine Leiomyoma Hospitalization 5/1/2002 54 Female 152 lb 6/26/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 6/24/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Death Female 6/25/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 7/21/2008 Lawyer United States
Primary
Secondary
Breast Disorder Other Serious Female 9/11/2008 Consumer United States
Primary
Secondary
Paget's Disease Of The Breast Other Serious 9/16/2003 Female 11/5/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 7/24/2003 56 Female 10/9/2008 United States
Primary
Secondary
Paget's Disease Of The Breast Other Serious 9/16/2003 Female 11/20/2008 Consumer United States
Primary
Secondary
Injury Other Serious Female 1/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/28/2004 53 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/17/2004 56 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2004 63 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 6/12/2003 63 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/14/2002 59 Female 165 lb 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Disorder Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Disorder Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 12/30/2002 55 Female 12/19/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Cerebrovascular Accident Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Disorder Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/2002 70 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2004 56 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/13/2003 61 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 5/8/2003 67 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/13/2004 Female 2/12/2009 Consumer United States
Primary
Secondary
Cutaneous Lupus Erythematosus Other Serious 1/1/2004 Female 2/13/2009 Consumer United States
Primary
Secondary
Breast Disorder Other Serious 12/11/1992 Female 2/23/2009 Consumer United States
Primary
Secondary
Thrombophlebitis Superficial Hospitalization 8/1/1993 Female 3/23/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/8/2003 Female 3/30/2009 United States
Primary
Secondary
Malignant Neoplasm Progression Other Serious 11/28/2005 Female 4/1/2009 Consumer United States
Primary
Secondary
Hot Flush Other Serious 1/1/2003 Female 161 lb 5/4/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/8/2003 67 Female 146 lb 5/19/2009 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 10/1/2002 Female 6/9/2009 Lawyer United States
Primary
Secondary
Concomitant
Scleroderma Other Serious 12/1/2001 Female 8/4/2009 Consumer United States
Primary
Secondary
Scleroderma Other Serious 12/1/2001 Female 8/7/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Male 8/17/2009 Lawyer United States
Primary
Secondary
Uterine Leiomyoma Hospitalization 5/1/2002 54 Female 152 lb 9/1/2009 Lawyer United States
Primary
Secondary
Concomitant
Scleroderma Other Serious 12/1/2001 Female 12/4/2009 Consumer United States
Primary
Secondary
Breast Cancer Stage I Other Serious 6/27/2003 57 Female 183 lb 5/19/2010 Consumer United States
Primary
Secondary
Concomitant
Scleroderma Other Serious 1/1/2006 60 Female 119 lb 5/19/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/27/2003 62 Female 115 lb 5/19/2010 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/27/2003 62 Female 115 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Scleroderma Other Serious 1/1/2006 60 Female 119 lb 5/19/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/27/2003 62 Female 115 lb 5/19/2010 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Stage I Other Serious 6/27/2003 57 Female 183 lb 5/19/2010 Consumer United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 6/30/2003 64 Female 9/17/2010 Lawyer United States
Primary
Secondary

Drug Data